Stocktoria

Apogee Therapeutics, Inc. APGE

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2023-07-14

Apogee Therapeutics, Inc. statistics & valuation

Market cap$10.0B
Return on capital-31.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2022202320242025
Operating margin (%)
2022202320242025
Return on equity (%)
2022202320242025
Shares outstanding
2.5M 48.3M 58.1M 68.4M 2022202320242025
Net debt ($)
2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-26.20% -20.90% -24.20% -27.30% 2022202320242025
Free cash flow margin (%)
2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
-$16.16 -$3.36 -$3.30 -$4.22 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Return on assets-27.3%-24.2%-20.9%-26.2%
Current ratio26.5718.5519.3815.24

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.